Background: Over the last decade, numerous studies have investigated the administration of monoclonal anti-amyloid antibodies (AAAs) as a therapeutic approach in Alzheimer’s disease (AD). The purpose of this umbrella review is to summarize current knowledge concerning the efficacy and safety of FDA- and EMA-approved AA...
S. Kalampokini, Iraklis Keramidiotis, Antonis Frontistis et al.· Journal of Clinical Medicine· 0 citations
Evidence from included studies suggests that pain may occur early and represents a significant contributor to disease burden, and CANVAS should be considered in patients with idiopathic sensory neuronopathy, even when pain is present.
Panayiota Neophytou, S. Kalampokini, Constantinos Avraam et al.· Pain and Therapy· 1 citation
Epileptic seizures in patients with KBG syndrome are usually generalized and have an onset between infancy and mid-teens, and common epileptological features in KBG syndrome comprise the good response to antiseizure medication and, in most cases, the remitting nature of epilepsy.
S. Kalampokini, Evripidis Pityrigkas, Zoi Kallia et al.· Epileptic disorders· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.